Clinical characteristics of patient with type 2 Diabetes Mellitus

A prospective clinical study to evaluate exclusive clinical characteristics of patient with type 2 Diabetes Mellitus prescribed with Glaritusâ?¢ and/or tablet O-Glimadayâ?¢: APEX GO - APEX GO

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2020/11/029433

Enrollment

10500

Registered

2020-11-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Glaritusâ?¢ (Recombinant DNA origin insulin glargine injection) O-Glimadayâ?¢ fixed dose combination tablet of Glimepiride and Metformin: Glaritusâ?¢ - 100IU/ml for Intravenous or Subc

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patient (age 18-80 years) of type 2 diabetes mellitus prescribed with either Glaritus and/or O Glimaday 2. Patient willing to comply with the protocol and written Informed Consent

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

Measure	Time frame
Demographic Characteristics Clinical Characteristics Treatment pattern of Glaritusâ?¢ and/or O-Glimadayâ?¢ Timepoint: during visit	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Khokan Debnath

Wockhardt Ltd.

singole@wockhardt.com022-26596775

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026